Stammdaten
Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It also develops Milciclib (TZLS-201), a small molecule inhibitor of various cyclin-dependent kinases, tropomycin receptor kinases, and Src family kinases controlling cell growth and malignant progression of cancer; and anti-Interleukin 6 receptor (IL6R) mAb (TZLS-501), a fully human monoclonal antibody for the treatment of IL6-induced inflammation and to treat COVID-19 patients. The company was incorporated in 1998 and is headquatered in London, the United Kingdom.
Unternehmen & Branche
| Name | Tiziana Life Sciences Ltd |
|---|---|
| Ticker | TLSA |
| CIK | 0001723069 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | G88912103 |
|---|---|
| ISIN | USG889121038 |
| Typ | Common Stock |
| Marktkapitalisierung | 75,5 Mio. USD |
| Beta | 0,37 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| MARSHALL WACE, LLP | 282,017 | 0 | 282,017 | 420,205 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 110,290 | 0 | 110,290 | 164,332 | Neu | +100,0% | |
| UBS Group AG | 105,218 | 0 | 105,218 | 156,775 | Neu | +100,0% | |
| Zhang Financial LLC | 99,900 | 0 | 99,900 | 148,851 | Neu | +100,0% | |
| Focus Partners Wealth | 79,971 | 0 | 79,971 | 119,157 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 78,204 | 0 | 78,204 | 116,523 | Neu | +100,0% | |
| HSBC HOLDINGS PLC | 62,437 | 0 | 62,437 | 94,280 | Neu | +100,0% | |
| MORGAN STANLEY | 52,156 | 0 | 52,156 | 77,713 | Neu | +100,0% | |
| MILLENNIUM MANAGEMENT LLC | 51,589 | 0 | 51,589 | 76,868 | Neu | +100,0% | |
| EWA, LLC | 46,051 | 0 | 46,051 | 68,616 | Neu | +100,0% | |
| SIMPLEX TRADING, LLC | 36,900 | 0 | 36,900 | 54,981 | Neu | +100,0% | |
| LPL Financial LLC | 24,622 | 0 | 24,622 | 36,687 | Neu | +100,0% | |
| GROUP ONE TRADING LLC | 18,300 | 0 | 18,300 | 27,267 | Neu | +100,0% | |
| OSAIC HOLDINGS, INC. | 16,300 | 0 | 16,300 | 24,287 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 13,089 | 0 | 13,089 | 19,503 | Neu | +100,0% | |
| Corient Private Wealth LLC | 12,229 | 0 | 12,229 | 18,221 | Neu | +100,0% | |
| JNBA Financial Advisors | 12,000 | 0 | 12,000 | 17,880 | Neu | +100,0% | |
| WEALTH ALLIANCE, LLC | 10,350 | 0 | 10,350 | 15,422 | Neu | +100,0% | |
| WELLS FARGO & COMPANY/MN | 1,952 | 0 | 1,952 | 2,908 | Neu | +100,0% | |
| US BANCORP \DE\ | 1,000 | 0 | 1,000 | 1,490 | Neu | +100,0% | |
| JONES FINANCIAL COMPANIES LLLP | 650 | 0 | 650 | 969 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 518 | 0 | 518 | 772 | Neu | +100,0% | |
| Bernard Wealth Management Corp. | 500 | 0 | 500 | 745 | Neu | +100,0% | |
| Tradewinds Capital Management, LLC | 258 | 0 | 258 | 385 | Neu | +100,0% | |
| Steward Partners Investment Advisory, LLC | 245 | 0 | 245 | 365 | Neu | +100,0% | |
| HRT FINANCIAL LP | 24,504 | 0 | 24,504 | 36 | Neu | +100,0% | |
| CWM, LLC | 500 | 0 | 500 | 1 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
Fail-to-Deliver (6 Monate)
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-03-31 | 88 | 1,24 | 109 |
| 2026-03-27 | 1.876 | 1,25 | 2.345 |
| 2026-03-19 | 1.429 | 1,26 | 1.801 |
| 2026-03-17 | 1.365 | 1,34 | 1.829 |
| 2026-03-13 | 12.292 | 1,26 | 15.488 |
| 2026-03-11 | 2.310 | 1,37 | 3.165 |
| 2026-02-25 | 9.513 | 1,34 | 12.747 |
| 2026-02-24 | 39 | 1,25 | 49 |
Top-Fondshalter
Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| MARSHALL WACE, LLP | 282,017 | 420,205 | 25.23 |
| GOLDMAN SACHS GROUP INC | 110,290 | 164,332 | 9.87 |
| UBS Group AG | 105,218 | 156,775 | 9.41 |
| Zhang Financial LLC | 99,900 | 148,851 | 8.94 |
| Focus Partners Wealth | 79,971 | 119,157 | 7.16 |
| GEODE CAPITAL MANAGEMENT, LLC | 78,204 | 116,523 | 7.00 |
| HSBC HOLDINGS PLC | 62,437 | 94,280 | 5.66 |
| MORGAN STANLEY | 52,156 | 77,713 | 4.67 |
| MILLENNIUM MANAGEMENT LLC | 51,589 | 76,868 | 4.62 |
| EWA, LLC | 46,051 | 68,616 | 4.12 |
| SIMPLEX TRADING, LLC | 36,900 | 54,981 | 3.30 |
| LPL Financial LLC | 24,622 | 36,687 | 2.20 |
| GROUP ONE TRADING LLC | 18,300 | 27,267 | 1.64 |
| OSAIC HOLDINGS, INC. | 16,300 | 24,287 | 1.46 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 13,089 | 19,503 | 1.17 |
| Corient Private Wealth LLC | 12,229 | 18,221 | 1.09 |
| JNBA Financial Advisors | 12,000 | 17,880 | 1.07 |
| WEALTH ALLIANCE, LLC | 10,350 | 15,422 | 0.93 |
| WELLS FARGO & COMPANY/MN | 1,952 | 2,908 | 0.17 |
| US BANCORP \DE\ | 1,000 | 1,490 | 0.09 |